Putting the Bully in the Bully Pulpit: The Democrats' Plan to Cut Drug Prices

Legislation to force price negotiation under Medicare Part D is likely to end in a stalemate. But manufacturers can't afford to relax: the Democrats plan to turn up the pressure even if a law never passes. First they will compare Part D prices to other benchmarks. Then the bullying begins.

By Michael McCaughan

For Big Pharma companies, it seemed like the longest 100 hours in history. True to their word, the new Democratic...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet